CN1276731C - 一种饮料 - Google Patents
一种饮料 Download PDFInfo
- Publication number
- CN1276731C CN1276731C CN200410016999.5A CN200410016999A CN1276731C CN 1276731 C CN1276731 C CN 1276731C CN 200410016999 A CN200410016999 A CN 200410016999A CN 1276731 C CN1276731 C CN 1276731C
- Authority
- CN
- China
- Prior art keywords
- beverage
- effect
- radix glycyrrhizae
- cough
- lung
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000036541 health Effects 0.000 title claims abstract description 12
- 235000013361 beverage Nutrition 0.000 title abstract description 29
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 9
- 241001116477 Adenophora triphylla Species 0.000 claims description 8
- 244000144725 Amygdalus communis Species 0.000 claims description 7
- 235000011437 Amygdalus communis Nutrition 0.000 claims description 7
- 235000020224 almond Nutrition 0.000 claims description 7
- 235000013399 edible fruits Nutrition 0.000 claims description 7
- 241000428813 Gomphrena Species 0.000 claims description 6
- 244000241872 Lycium chinense Species 0.000 claims description 6
- 235000015468 Lycium chinense Nutrition 0.000 claims description 6
- 241000249864 Tussilago Species 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 206010011224 Cough Diseases 0.000 abstract description 17
- 208000006673 asthma Diseases 0.000 abstract description 11
- 210000004072 lung Anatomy 0.000 abstract description 10
- 241001412627 Adenophora liliifolia Species 0.000 abstract description 3
- 206010036790 Productive cough Diseases 0.000 abstract description 3
- 235000021552 granulated sugar Nutrition 0.000 abstract description 3
- 208000024794 sputum Diseases 0.000 abstract description 3
- 210000003802 sputum Anatomy 0.000 abstract description 3
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract description 2
- 206010019345 Heat stroke Diseases 0.000 abstract description 2
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract description 2
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract description 2
- 244000018633 Prunus armeniaca Species 0.000 abstract description 2
- 235000009827 Prunus armeniaca Nutrition 0.000 abstract description 2
- 240000000377 Tussilago farfara Species 0.000 abstract description 2
- 235000004869 Tussilago farfara Nutrition 0.000 abstract description 2
- 230000008901 benefit Effects 0.000 abstract description 2
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 abstract description 2
- 239000012752 auxiliary agent Substances 0.000 abstract 1
- 239000003053 toxin Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 22
- 239000003814 drug Substances 0.000 description 16
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 7
- 229960004949 glycyrrhizic acid Drugs 0.000 description 7
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 7
- 235000019410 glycyrrhizin Nutrition 0.000 description 7
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 7
- 239000004378 Glycyrrhizin Substances 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 3
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 244000241838 Lycium barbarum Species 0.000 description 3
- 235000015459 Lycium barbarum Nutrition 0.000 description 3
- 206010006451 bronchitis Diseases 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 230000000857 drug effect Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 229960003720 enoxolone Drugs 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 210000000867 larynx Anatomy 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- CWVRJTMFETXNAD-BMNNCGMMSA-N (1s,3r,4s,5r)-3-[(e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-1,4,5-trihydroxycyclohexane-1-carboxylic acid Chemical compound O[C@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-BMNNCGMMSA-N 0.000 description 2
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000001368 chlorogenic acid Nutrition 0.000 description 2
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 2
- 229940074393 chlorogenic acid Drugs 0.000 description 2
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 2
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- KRZBCHWVBQOTNZ-DLDRDHNVSA-N isochlorogenic acid Natural products O[C@@H]1[C@H](C[C@@](O)(C[C@H]1OC(=O)C=Cc2ccc(O)c(O)c2)C(=O)O)OC(=O)C=Cc3ccc(O)c(O)c3 KRZBCHWVBQOTNZ-DLDRDHNVSA-N 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 239000013049 sediment Substances 0.000 description 2
- 235000019605 sweet taste sensations Nutrition 0.000 description 2
- 235000015523 tannic acid Nutrition 0.000 description 2
- 229920002258 tannic acid Polymers 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 241000208671 Campanulaceae Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- QCDFBFJGMNKBDO-UHFFFAOYSA-N Clioquinol Chemical compound C1=CN=C2C(O)=C(I)C=C(Cl)C2=C1 QCDFBFJGMNKBDO-UHFFFAOYSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- YIKYNHJUKRTCJL-UHFFFAOYSA-N Ethyl maltol Chemical compound CCC=1OC=CC(=O)C=1O YIKYNHJUKRTCJL-UHFFFAOYSA-N 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- FURUXTVZLHCCNA-UHFFFAOYSA-N Liquiritigenin Natural products C1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 FURUXTVZLHCCNA-UHFFFAOYSA-N 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 241001347978 Major minor Species 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- 240000001949 Taraxacum officinale Species 0.000 description 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- CEYULKASIQJZGP-UHFFFAOYSA-L disodium;2-(carboxymethyl)-2-hydroxybutanedioate Chemical compound [Na+].[Na+].[O-]C(=O)CC(O)(C(=O)O)CC([O-])=O CEYULKASIQJZGP-UHFFFAOYSA-L 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 229940093503 ethyl maltol Drugs 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- JBQATDIMBVLPRB-UHFFFAOYSA-N isoliquiritigenin Natural products OC1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 JBQATDIMBVLPRB-UHFFFAOYSA-N 0.000 description 1
- YNWXJFQOCHMPCK-LXGDFETPSA-N isoliquiritin Chemical group O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1)=CC=C1\C=C\C(=O)C1=CC=C(O)C=C1O YNWXJFQOCHMPCK-LXGDFETPSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- FURUXTVZLHCCNA-AWEZNQCLSA-N liquiritigenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC=C2C(=O)C1 FURUXTVZLHCCNA-AWEZNQCLSA-N 0.000 description 1
- 238000003754 machining Methods 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 230000000422 nocturnal effect Effects 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000020561 organic beverage Nutrition 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Landscapes
- Non-Alcoholic Beverages (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
一种新型健康饮料,所包含的有效成分和配比(重量百分比)为:甘草:30-50份;款冬花:10-18份;南沙参:5-10份;金银花:5-15份;杏仁:5-10份,具有止咳化痰、润肺平喘、清热解毒、预防中暑的特点。且本饮料不需加入白砂糖等辅剂,即可获得很好的口感,甜味适中,可适用的人群较广,是一种具有开发前景的新型饮料。
Description
技术领域
本发明涉及一种饮料,尤其是一种新型健康、可提高人体机能、预防疾病的饮料。
背景技术
目前,饮料已成为人们生活中的一个重要部分,饮料的品种也越来越多起来,从矿泉水饮料到果汁,再到一些功能性保健饮料,饮料的市场越来越大。如专利“一种天然植物饮料机器加工工艺”,该发明公开了一种天然植物饮料及其加工工艺,它是采用菊花n-19%、红枣6-14%、薄荷12-19%、甘草2-9%、金银花6-12%、蒲公英7-12%、桑甚10-16%、焦麦16-24%这些天然植物原料,经过浸提、过滤、酶水解、高温灭酶、沉淀澄清等步骤加工而成。该发明将这些天然植物原料有机混合制成的饮料,营养丰富,具有消暑解渴、健脾润胃、补血滋阴、疏解肝郁等保健功效,但其止咳平喘、润肠通便、润肺生津、降压降脂等方面效果不太另人满意,另外,该饮料需加入异Vc--Na、柠檬酸钠、山梨酸钾、蛋白糖乙基麦芽酚、白砂糖等物质以调节口感,所以制备烦琐,而且因为糖类物质的引用减少了可适用人群的范围。
发明内容
本发明解决了现有饮料所存在的止咳平喘、润肠通便、润肺生津效果不佳,配方经济性较差等的技术问题,提供了一种具有很好的止咳化痰、润肺平喘、解毒通便等功效且配方经济的健康饮料。
本发明还解决了现有饮料所存在的使用辅助物质调节口感等的问题,提供了一种不需加入辅助物质,且口感很好的新型健康饮料。
本发明的上述技术目的是通过以下技术方案解决的:一种新型健康饮料,所包含的有效成分和配比(重量百分比)为:甘草:30-50份;款冬花:10-18份;南沙参:5-10份;金银花:5-15份;杏仁:5-10份。
甘草为豆科多年生草本植物,以根及根状茎入药,含甘草酸、甘草次酸、甘草内酯及黄酮类和香豆素类化合物。味甘、性平,有补脾益气、止咳祛痰、清热解毒之功能。主治脾胃虚弱,咳嗽气喘,痈疽疮毒等症,在食品工业及轻工业上也有广泛的用途。款冬花为菊科植物,别名冬花,九九花、看灯花。具有润肺下气、化痰止咳功能,主治急慢性支气管炎、喉痹、咳嗽气喘。南沙参为桔梗科多年生草本植物杏叶沙参、轮叶沙参的根,沙参的性味甘微寒,具有润肺止咳、养胃生津的功效。主要用于肺虚有热、干咳少痰或久咳声哑等症。南沙参甘涼柔润,能养胃而复津液,故也常用于胃阴耗伤、津少口渴等症。金银花蕾含黄酮类,为木犀草素及木犀草素-7-葡萄糖甙。并含肌醇绿原酸、异绿原酸和皂甙。绿原酸和异绿原酸为主要抗菌成分。可清热解毒,凉散风热。用于痈肿疔疮,喉痹丹毒,热毒,血痢,风热感冒,瘟病发热。杏仁可止咳平喘,为止咳平喘之要药,另外还有润肠通便等功效,用于阴虚血少之便秘。
新型健康饮料该配方根据药物的主辅关系组合而成,目的是使多味中药发挥协同作用,增强保健效果。甘草作为配方中的主要物质,其中含有的甘草甜素,可矫正杏仁等其他诸药的苦味。甘草甜素在机体内可水解生成一分子甘草次酸和两分子葡萄糖醛酸。甘草次酸具有皮质激素样的作用,能增加肝脏的解毒作用,与金银花并用可使该作用得到增强。甘草甜素属于有机酸,可与中药里的多种生物碱起化学反应,生成不易溶解的沉淀物,这些沉淀物在人体内的缓慢分解延长了发挥药效时间,又可使药性发作较缓,从而降低副作用。同时,甘草甜素还具有类似活性炭的吸附作用,能吸附其它各药物的化学成份,使其在体内逐渐释放,缓慢发挥药效。另外,甘草能增强配方中其它药物的功效,这与甘草所含的甘草甜素、甘草甙元、异甘草甙元有关。比如在镇痛、解痉、解热、抗炎、抑制胃液分泌和松驰平滑肌方面均有与其它药物的协同作用。甘草甜素还具有“助溶作用”,与其它药同煎,可增强其它药物成分在水中的溶解度,从而使药效增强。甘草本身虽无抗菌作用,但它能增强其它清热解毒药对细菌的抑制作用。
作为优选,所述的新型健康饮料有效成分和配比(重量百分比)为:甘草:35-40份;款冬花:12-15份;南沙参:6-8份;金银花:8-12份;杏仁:6-7份。该配比可得到更佳的药效和口感。
作为优选,所述的新型健康饮料的有效成分还包括千日红:5-10份;枇杷叶3-8份。千日红的叶子和花中含有大量鞣酸、苹果酸和其他药用成分,这些药用成分味淡微甜,可用于治疗气喘、小儿夜啼、支气管炎、百日咳等,具有清肺散结,消炎,降血脂、血压等功效。枇杷叶是一种有名的中药,其性凉、味苦。枇杷叶含有糖类、鞣酸等,具有清肺止咳、和胃止呕的功效,略有清暑止渴作用,常用于肺热咳嗽、呕吐或呃逆、吐血、衄血、折喉等症的治疗。具有消炎止咳作用的千日红的与款东花的配合使用,增强了各自原有的疗效,枇杷叶的加入进一步增强了主要成分甘草清肺平喘的功效,从而使得所得饮料的保健效果更佳。
作为优选,所述的新型健康饮料的有效成分还包括化橘红:5-8份;枸杞子:5-12份。化橘红可调理脾胃气机,化其痰湿浊邪。枸杞子为茄科植物枸杞的果实,含甜菜碱、枸杞多糖、胡萝卜素、核黄素、烟酸、维生素C等。枸杞子性平,味甘,可滋补肝肾,益精明目,用于虚劳精亏、腰膝酸痛、眩晕耳鸣、内热消渴、血虚萎黄、目昏不明等症,它能夠促进血液循环、防止动脉硬化、还可預防肝脏内脂肪的囤积,再加上枸杞内所含有的各种维他命、必需氨基酸及亚麻油酸全面性地的运作,更可以促进体内的新陈代谢,也能夠防止老化。在本配方中加入适量的化橘红和枸杞,可在一定程度上增强了其它药物的主要疗效,如甘草、金银花等,同时由于药物间的相互作用,减轻或消除了药物原有的毒性或副作用,使得该配方更好的发挥疗效,消除毒副作用。
因此,本发明具有止咳化痰、润肺平喘、清热解毒、预防中暑的特点。且本品不需加入白砂糖等辅剂,即可获得很好的口感,甜味适中,可适用的人群较广(糖尿病人群可使用)。
具体实施方式
下面通过具体实施例,并结合附图,对本发明的技术方案作进一步具体的说明。
表1饮料中各有效物质所占的重量百分比(%)
实施例1:取12份的款冬花、10份的千日红、8份枇杷叶、5份的南沙参、7份的化橘红、8份的金银花、5份的枸杞子、10份的杏仁和35份的甘草(如表1所示),水提取煎制制得提取液,经过滤杀菌等程序后得该健康饮料,该饮料不需加入其它辅剂就可具有很好的口感,且甜味适中,是一种理想的健康饮料。
实施例2-5同实施例1。
Claims (2)
1、一种保健饮料,由原料经过水提取而制成,其特征在于所述原料的百分组成为:甘草30-50%;款冬花10-18%;南沙参5-10%;金银花5-15%;杏仁5-10%;千日红5-10%;枇杷叶3-8%;化橘红5-8%;枸杞子5-12%。
2、根据要求1所述的一种保健饮料,其特征在于所述的原料的优选百分组成为:甘草35-40%;款冬花12-15%;南沙参6-8%;金银花8-12%;杏仁6-7%;千日红5-10%;枇杷叶3-8%;化橘红5-8%;枸杞子5-12%。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200410016999.5A CN1276731C (zh) | 2004-03-15 | 2004-03-15 | 一种饮料 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200410016999.5A CN1276731C (zh) | 2004-03-15 | 2004-03-15 | 一种饮料 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1669485A CN1669485A (zh) | 2005-09-21 |
| CN1276731C true CN1276731C (zh) | 2006-09-27 |
Family
ID=35041088
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200410016999.5A Expired - Fee Related CN1276731C (zh) | 2004-03-15 | 2004-03-15 | 一种饮料 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1276731C (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9364519B2 (en) | 2011-09-01 | 2016-06-14 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical composition for use in the treatment of a neurodegenerative disease |
| US9408893B2 (en) | 2011-08-29 | 2016-08-09 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical combination for use in glycemic control in diabetes type 2 patients |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101301416B (zh) * | 2008-06-03 | 2012-04-11 | 李亚萍 | 一种治疗百日咳的汤剂药物 |
| CN102688309A (zh) * | 2012-06-14 | 2012-09-26 | 李良 | 治疗咳嗽的龙舌叶中药汤剂及制备方法 |
| CN102871175B (zh) * | 2012-10-15 | 2014-07-23 | 山东好当家海洋发展股份有限公司 | 一种润肺止咳营养饮料及其制备方法 |
| CN105232911B (zh) * | 2015-10-12 | 2019-05-03 | 杨立国 | 一种中药组合物 |
| CN106729277A (zh) * | 2016-12-20 | 2017-05-31 | 蚌埠鲲鹏食品饮料有限公司 | 一种止咳润肺饮料 |
| CN108704051A (zh) * | 2018-08-17 | 2018-10-26 | 河南润弘本草制药有限公司 | 一种治疗咳嗽的中药膏及其制备方法 |
| CN115634257A (zh) * | 2022-07-06 | 2023-01-24 | 何燕 | 一种丽川润肺饮品及其应用 |
-
2004
- 2004-03-15 CN CN200410016999.5A patent/CN1276731C/zh not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9408893B2 (en) | 2011-08-29 | 2016-08-09 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical combination for use in glycemic control in diabetes type 2 patients |
| US9364519B2 (en) | 2011-09-01 | 2016-06-14 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical composition for use in the treatment of a neurodegenerative disease |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1669485A (zh) | 2005-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101433188B1 (ko) | 아미노산, 활성종합비타민 및 한방생약재를 함유하는 숙취해소용 조성물 및, 그 제조방법 | |
| KR20110073717A (ko) | 기능성 식품 및 이의 제조방법 | |
| Moore | Los remedios: traditional herbal remedies of the Southwest | |
| CN1389130A (zh) | 营养凉茶及其制备方法 | |
| CN1276731C (zh) | 一种饮料 | |
| CN101773595A (zh) | 清肝明目中药茶 | |
| KR20120131337A (ko) | 인진쑥, 헛개나무, 민들레, 대추, 갈근 및 오가피의 각각의 추출물을 주성분으로 함유하는 기능성 음료 조성물 | |
| KR20050012203A (ko) | 천식의 예방 및 치료에 효능이 있는 건강음료의 제조방법 | |
| KR101080565B1 (ko) | 고장초 추출물이 포함된 액상차 및 그 제조방법 | |
| KR20020037218A (ko) | 한약재 증류수를 이용한 다이어트 음료수 제조방법 | |
| CN105076617A (zh) | 一种苦荞茶及其制备方法 | |
| CN105878812A (zh) | 以金花茶-石斛为原料的解酒饮料及其生产方法 | |
| CN103417875B (zh) | 一种治疗慢性支气管炎的中药制剂及其制备方法 | |
| KR100670155B1 (ko) | 복방차료제를 함유하는 숙취완화용 드링크 조성물 및 그제조방법 | |
| CN1136781C (zh) | 人参八宝茶 | |
| CN117599125A (zh) | 一种用于治疗骨质疏松症的补钙壮骨中药组合物及制法和应用 | |
| CN1911060A (zh) | 一种凉茶 | |
| CN106834032A (zh) | 一种露酒、制备方法及其制备治痛风保健品或药剂的应用 | |
| KR102462077B1 (ko) | 흑홍삼 농축액이 가미된 경옥고 조성물 및 상기 조성물로 조성된 경옥고 | |
| CN107582796A (zh) | 一种消炎利咽清新止咳中药含片及其制备方法 | |
| KR20250124685A (ko) | 기침, 가래 해소 효과를 갖는 천연 한방약재 복합 조성물 및 그 제조방법 | |
| CN1080489A (zh) | 一种保健饮料的制造方法 | |
| CN115944695A (zh) | 一种具有安神、健脾养胃组合物及其颗粒剂的制备方法 | |
| CN104001083B (zh) | 一种用于治疗支气管哮喘的中药制剂及制作方法 | |
| CN1349751A (zh) | 姜茶及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |